DK1140110T3 - Klatrater af dehydroepiandrosteron og korresponderende farmaceutiske sammensætninger - Google Patents

Klatrater af dehydroepiandrosteron og korresponderende farmaceutiske sammensætninger

Info

Publication number
DK1140110T3
DK1140110T3 DK99963559T DK99963559T DK1140110T3 DK 1140110 T3 DK1140110 T3 DK 1140110T3 DK 99963559 T DK99963559 T DK 99963559T DK 99963559 T DK99963559 T DK 99963559T DK 1140110 T3 DK1140110 T3 DK 1140110T3
Authority
DK
Denmark
Prior art keywords
dehydroepiandrosterone
pharmaceutical compositions
corresponding pharmaceutical
climb rates
climb
Prior art date
Application number
DK99963559T
Other languages
English (en)
Inventor
Mora Paolo Corvi
Original Assignee
Euphar Group Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euphar Group Srl filed Critical Euphar Group Srl
Application granted granted Critical
Publication of DK1140110T3 publication Critical patent/DK1140110T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99963559T 1998-12-18 1999-12-16 Klatrater af dehydroepiandrosteron og korresponderende farmaceutiske sammensætninger DK1140110T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002745A IT1304190B1 (it) 1998-12-18 1998-12-18 Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche
PCT/EP1999/010010 WO2000037109A2 (en) 1998-12-18 1999-12-16 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK1140110T3 true DK1140110T3 (da) 2003-10-20

Family

ID=11381280

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99963559T DK1140110T3 (da) 1998-12-18 1999-12-16 Klatrater af dehydroepiandrosteron og korresponderende farmaceutiske sammensætninger

Country Status (24)

Country Link
EP (1) EP1140110B1 (da)
JP (1) JP2002532565A (da)
KR (1) KR100693514B1 (da)
CN (1) CN1198620C (da)
AR (1) AR021663A1 (da)
AT (1) ATE243517T1 (da)
AU (1) AU759979B2 (da)
BR (1) BR9916288A (da)
CA (1) CA2355148A1 (da)
CO (1) CO5231137A1 (da)
DE (1) DE69909128T2 (da)
DK (1) DK1140110T3 (da)
EA (1) EA003304B1 (da)
ES (1) ES2203232T3 (da)
HU (1) HU225414B1 (da)
IL (2) IL143776A0 (da)
IT (1) IT1304190B1 (da)
NZ (1) NZ512795A (da)
PE (1) PE20001379A1 (da)
PT (1) PT1140110E (da)
TR (1) TR200101766T2 (da)
TW (1) TWI225791B (da)
WO (1) WO2000037109A2 (da)
ZA (1) ZA200105223B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2815860B1 (fr) * 2000-10-26 2003-12-12 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou precurseur ou derive de celle-ci et au moins un agent myorelaxant
EP1285927A3 (de) * 2001-08-16 2005-06-29 Schering Aktiengesellschaft Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
ITMI20021074A1 (it) * 2002-05-20 2003-11-20 Actimex S R L Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione
ITMI20022549A1 (it) * 2002-12-02 2004-06-03 Actimex S R L Composizione quaternaria comprendente come sostanza attiva la propolis.
KR100771411B1 (ko) 2004-04-01 2007-10-30 에프. 호프만-라 로슈 아게 피리미딘-2,4,6-트리온의 시클로덱스트린 포접 복합체
WO2006137433A1 (ja) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. レボカバスチンを可溶化させた水性薬剤
ITPD20050224A1 (it) * 2005-07-19 2007-01-20 Actimex Srl Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego
US8268806B2 (en) * 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
HUE025350T2 (en) * 2011-07-19 2016-02-29 Pantarhei Bioscience Bv Tablets containing dehydroepiandrosterone (DHEA)
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
WO2014172706A1 (en) * 2013-04-19 2014-10-23 University Of Houston System Cocrystalline dhea formulations
ES2914305T3 (es) * 2017-12-26 2022-06-09 Ind Tech Res Inst Composición para mejorar la solubilidad de sustancias poco solubles, uso de la misma y formulación compleja que contiene la misma
EP3666260A1 (en) * 2018-12-13 2020-06-17 Laboratorios Leon Farma SA Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
US4978532A (en) * 1989-08-11 1990-12-18 Pharmedic Co. Dosage form for administration of dehydroepiandrosterone
US5120720A (en) * 1990-09-20 1992-06-09 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
WO1994004155A1 (en) * 1992-08-19 1994-03-03 Health Resource Institute, Ltd. Dehydroepiandrosterone therapy for the treatment of eye disorders
WO1995015746A1 (en) * 1993-12-10 1995-06-15 The School Of Pharmacy Liposome delivery systems
IL124001A (en) * 1995-11-13 2004-07-25 Supergen Inc Composition for administration of steroids

Also Published As

Publication number Publication date
ITMI982745A1 (it) 2000-06-18
HU225414B1 (en) 2006-11-28
WO2000037109A3 (en) 2000-09-14
NZ512795A (en) 2003-08-29
HUP0104822A3 (en) 2002-08-28
AU759979B2 (en) 2003-05-01
DE69909128T2 (de) 2004-05-06
JP2002532565A (ja) 2002-10-02
IL143776A0 (en) 2002-04-21
PE20001379A1 (es) 2000-11-25
ATE243517T1 (de) 2003-07-15
EA003304B1 (ru) 2003-04-24
CA2355148A1 (en) 2000-06-29
TR200101766T2 (tr) 2001-12-21
EP1140110B1 (en) 2003-06-25
CO5231137A1 (es) 2002-12-27
KR20010086109A (ko) 2001-09-07
WO2000037109A2 (en) 2000-06-29
IT1304190B1 (it) 2001-03-08
AU1981000A (en) 2000-07-12
PT1140110E (pt) 2003-11-28
CN1333686A (zh) 2002-01-30
EP1140110A2 (en) 2001-10-10
DE69909128D1 (de) 2003-07-31
BR9916288A (pt) 2001-10-16
IL143776A (en) 2007-03-08
ES2203232T3 (es) 2004-04-01
EA200100674A1 (ru) 2001-12-24
CN1198620C (zh) 2005-04-27
TWI225791B (en) 2005-01-01
AR021663A1 (es) 2002-07-31
ZA200105223B (en) 2002-09-25
KR100693514B1 (ko) 2007-03-14
HUP0104822A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
DK1123313T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
NO993217L (no) Broenntetningssammensetninger og fremgangsmåter
DK0969836T3 (da) Lactosefri, ikke-vandsugende og vandfri farmaceutiske sammensætninger af descarbethoxyloratadin
IS6304A (is) Kínasólínefnasambönd og lyfjafræðilegar efnasamsetningar sem innihalda þau
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
DE69918233D1 (de) Polymilchsäure zusammensetzung und daraus hergestellter film
DK1109453T3 (da) Sammensætninger og fremgangsmåder til behandling af mitokondrielle sygdomme
NO20016277L (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
EA199900373A3 (ru) Фармацевтические композиции
NO20005017L (no) Metoder og viskøse sammensetninger for behandling av brønner
NO20002165D0 (no) Farmasøytiske blandinger inneholdende cyklodekstriner og taksoider
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
NO995925D0 (no) Farmasöytiske sammensetninger omfattende cyklodekstriner
NO20006488D0 (no) Sammensetning og anvendelse
DE69918842D1 (de) Desinfektionszusammensetzungen und verfahren
IS2841B (is) Samstæða hluta og lyfjasamsetningar
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DK0994706T3 (da) Præparater til oral indgivelse af taxaner og anvendelse deraf
NO20004399L (no) Koleinsyreamider og farmasøytiske sammensetninger
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
IS2087B (is) Lyfjasamsetningar af tizoxaníði og nitazoxaníði
DE69917071D1 (de) Klebstoffzusammensetzungen und klebebahnen
DE69816395D1 (de) Silatranderivate und diese enthaltende härtbare Silikonzusammensetzungen
EP1073333A4 (en) S-RABEPRAZOLE COMPOSITIONS AND METHODS